Surprises and Unanswered Questions in the List of Drugs Selected for Direct Negotiations What happened? The Department of Health and Human Services (HHS) released its intended targets for Medicare price negotiations on August 29, 2023, putting affected biopharmaceutical companies on official notice for lower Medicare reimbursements in 2026 (and possible market repercussions more immediately). Need […]
Specialty Pharmacies and the Biosimilar Boom Understanding the various revenue streams of Specialty Pharmacy (SP) network partners is the key to identifying how biopharma can best incentivize SPs. A critical success factor for biosimilars is the ability to deploy unique contracting strategies that will not affect Average Sale Price (ASP). In the latest research from […]
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
